← FDA Drug Approvals (Drugs@FDA)

EPHEDRINE SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2026-03-19

Drug application

FDA Application #

ANDA219991

Application type

Abbreviated New Drug Application (Generic)

Brand name

EPHEDRINE SULFATE

Generic name

Ephedrine Sulfate

Active ingredients

EPHEDRINE SULFATE

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

First approval

2026-03-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown